Eurican DAPPi Lyophilisate and Solvent for Suspension for Injection
Active ingredients: Canine adenovirus, Canine distemper virus, Canine parainfluenza virus, Canine parvovirus
Form
Injection
Species
Manufacturer
Boehringer Ingelheim Animal Health UK Limited
VMD MA No.
08327/5024
What it's used for
Active immunisation of dogs to: - prevent mortality and clinical signs caused by canine distemper virus (CDV), - prevent mortality and clinical signs cause...
Full indications, dosage and side effects ↓The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Canine adenovirus + Canine d...
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Eurican DAPPi Lyophilisate and Solvent for Suspension for Injection — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.
- prevent mortality and clinical signs caused by canine distemper virus (CDV),
- prevent mortality and clinical signs caused by infectious canine hepatitis virus
(CAV-1),
- reduce viral excretion during respiratory disease caused by canine adenovirus
type 2 (CAV-2),
- prevent mortality, clinical signs and viral excretion caused by canine parvovirus
(CPV)*,
- reduce viral excretion caused by canine parainfluenza virus type 2 (CPiV).
Revised June 2024
AN: 00737/2023 & 03368/2023Page 2 of 6
Onset of immunity: 2 weeks after the second injection of the primary vaccination
course for all strains.
Duration of immunity: at least one year after the second injection of the primary
vaccination course for all strains.
Current available challenge and serological data show that protection for distemper
virus, adenovirus and parvovirus* lasts for 2 years after primary vaccination course
followed by a first annual booster.
Any decision to adapt the vaccination schedule of this veterinary medicinal product
needs to be made on a case by case basis, taking into account the vaccination
history of the dog and the epidemiological context.
*Protection has been demonstrated against canine parvovirus type 2a, 2b and 2c
either by challenge (type 2b) or serology (type 2a and 2c).
DAP/DAPPi or a compatible Boehringer Ingelheim vaccine (Eurican LR, Eurican L,
Eurican Lmulti or Eurican L4) where available. Shake well before use. The entire
contents of the reconstituted vial should be administered as a single dose.
The reconstituted content shall be an opalescent yellow to orange suspension.
Inject a 1-ml dose subcutaneously according to the following schedule:
Primary vaccination:
Two injections separated by an interval of 4 weeks from 7
weeks of age.
When administered with Boehringer Ingelheim's vaccines containing rabies, the
minimum age for vaccination is 12 weeks of age.
In cases where high levels of maternally derived antibodies are suspected by the
veterinarian and the primary vaccination course was completed before 16 weeks of
age, a third injection using a Boehringer Ingelheim vaccine containing Distemper,
Adenovirus and Parvovirus is recommended from 16 weeks of age, at least 3 weeks
after the second injection.
Revised June 2024
AN: 00737/2023 & 03368/2023Page 4 of 6
Revaccination: Administer one dose 12 months after completion of the primary
vaccination course. Dogs should be revaccinated with a single booster dose on an
annual basis.
immediately after injection. It usually regresses within 1-6 days. This can, on some
occasions, be accompanied by slight pruritus, heat and pain at the injection site.
Transient lethargy and emesis may also be commonly observed.
Anorexia, polydipsia, hyperthermia, diarrhoea, muscle tremor, muscle weakness and
injection site cutaneous lesions may uncommonly be observed.
Hypersensitivity reactions (facial oedema, anaphylactic shock, urticaria) may rarely
occur, some of which are life-threatening. Appropriate symptomatic treatment should
promptly be provided.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
Revised June 2024
AN: 00737/2023 & 03368/2023Page 3 of 6
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Special precautions for use in animals
Apply usual aseptic procedures.
After vaccination, the live CAV-2 and CPV vaccine strains can transiently be shed
without adverse consequence for in-contact animals.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
administered with Eurican LR, Eurican L, Eurican Lmulti or Eurican L4 vaccines
(used as solvent) where available.
Safety and efficacy data are available which demonstrate that this vaccine can be
administered on the same day but not mixed with Rabisin.
When administered with Boehringer Ingelheim's vaccines containing rabies, the
minimum age for vaccination is 12 weeks of age.
When mixed with the Eurican LR vaccine a small and transient nodule (maximum
size 1.5 cm) at the injection site may be induced due to the presence of aluminium
hydroxide and a slight swelling (~4 cm) may occur after the injection at injection site,
regressing generally within 1-4 days.
When mixed with the Eurican L4 vaccine a swelling (less than 6 cm) may very
commonly occur at the injection site, disappearing within 8 days, anorexia may
commonly occur and vocalisation, tachycardia and tachypnoea may uncommonly be
observed. For Eurican L4, no safety data in pregnant bitches are available for the
additional inactivated strain, Leptospira Australis.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product except the products mentioned above. A
decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case by case basis.
Store and transport refrigerated (2 C – 8 C).
Protect from light.
Do not freeze.
5. IMMUNOLOGICAL PROPERTIES
ATCvet code: QI07AD04.
Pharmacotherapeutic group: Immunologicals for Canidae, live viral vaccines for dogs.
Vaccine against canine distemper virus, canine adenovirus (CAV-1 and CAV-2),
canine parvovirus and parainfluenza type 2 infections.
After administration, the vaccine induces an immune response in dogs against
distemper, adenoviroses (CAV-1 and CAV-2), parvovirosis and parainfluenza type 2
respiratory infections demonstrated by challenge and by the presence of antibodies.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Related Conditions
Other Products Containing Canine adenovirus
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Canigen DHP Lyophilisate and Solvent for Suspension for Injection for Dogs
POM-VIntervet International B.V.
Canigen DHPPi Lyophilisate for Suspension for Injection for Dogs
POM-VIntervet International B.V.
Canixin DHPPi Lyophilisate and Solvent for Suspension for Injection for Dogs
POM-VVirbac
Canixin DHPPi Lyophilisate and Solvent for Suspension for Injection for Dogs
POM-VVirbac
Canixin DHPPi/L
POM-VVIRBAC
CANIXIN DHPPi/L Lyophilisate and Suspension for Suspension for Injection for Dogs
POM-VVirbac
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
VetBox Flea & Worm Protection for Dogs
Vet-founded monthly parasite subscription. Flea, tick and worm protection delivered to your door. Founded by Dr Will Woodley, protecting 30,000+ pets.
We may earn a small commission if you purchase through these links, at no extra cost to you.
Related Medications
Aftopur AlSap
POM-VFoot-and-mouth disease virus
Aftopur AlSap
POM-VFoot-and-mouth disease virus
Aftopur DOE
POM-VFoot-and-mouth disease virus
Aftopur DOE
POM-VFoot-and-mouth disease virus
Alpha Ject Micro 1 PD Emulsion for Injection for Atlantic Salmon
POM-VSalmon pancreas disease virus
Alpha Ject Micro 1 PD Emulsion for Injection for Atlantic Salmon
POM-VSalmon pancreas disease virus
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.